Live tape
Top 8, mentions 7d7,604NVDA1,584 mentions▲ +0.08GOOGL1,253 mentions▲ +0.03NKE991 mentions+0.01GPRO921 mentions▲ +0.08AVGO898 mentions▲ +0.05META733 mentions▲ +0.06DELL660 mentions▲ +0.07AAPL564 mentions▲ +0.07

Equity · Real Estate

AHR

American Healthcare REIT, Inc. · NYSE

$56.52 +2.38% 1D Finazon · prior-day close · Sep 1, 2026
Price · Chart
Our own end-of-day closes 61 sessions
$60 $45 5 Jun 1 Sep

The line runs $47.49 on 5 June through $56.52 on 1 September, on a scale from $45 to $60. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of AHR over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $47.49 on 5 June 2026 through $56.52 on 1 September 2026.

Market cap $12.3B
P/E (TTM) 83.1
52-week range $40.17 – $58
Avg volume 317.8K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 2, 2026

AHR insider trades

SEC Form 4

AHR has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 11 November 2025.

Date Insider Type Shares Value
11 Nov 2025 Foster Mark E. EVP, GC & Secretary Sell 1,500 $74K
10 Nov 2025 Hanson Jeffrey T Sell 20,010 $994K
03 Sep 2025 Foster Mark E. EVP, GC & Secretary Sell 3,850 $161K

AHR reported financials

SEC EDGAR XBRL

AHR reported revenue of $2.1B for the fiscal year ended 31 Dec 2025. Net income over the same period was $69.8M.

Figure Reported Period
Revenue $2.1B 31 Dec 2025 fiscal year
Net income $69.8M 31 Dec 2025 fiscal year
Diluted EPS $0.42 31 Dec 2025 fiscal year
Total assets $5.7B 30 Jun 2026 at period end
Total equity $3.7B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

AHR earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.16 $674M
31 Mar 2026 Q1 2026 $0.13 $651M
31 Dec 2025 FY 2025 $0.42 $2.26B
30 Sep 2025 Q3 2025 $0.33 $573M
30 Jun 2025 Q2 2025 $0.06 $543M
31 Mar 2025 Q1 2025 $-0.04 $541M
31 Dec 2024 FY 2024 $-0.29 $2.07B
30 Sep 2024 Q3 2024 $-0.03 $524M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

AHR institutional holders

SEC Form 13F

12 of the 45 institutional funds we track reported a AHR position for the quarter ended 30 Jun 2026 — a combined $484.0M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Balyasny Asset Management Added +125.3% shares 2,631,472 $137.2M
Millennium Management Added +2,300.7% shares 1,992,073 $103.9M
Two Sigma Investments Held (±25%) +20.2% shares 1,532,710 $79.9M
Citadel Advisors Added +71.5% shares 1,504,714 $78.5M
Soros Fund Management New position 428,630 $22.4M
Point72 Asset Management New position 408,275 $21.3M
Marshall Wace New position 355,049 $18.5M
AQR Capital Management Added +114.3% shares 159,183 $8.2M
Man Group Added +391.6% shares 142,769 $7.4M
Tudor Investment Corp New position 62,553 $3.3M

Showing the 10 largest of 12 reported positions. The figures above count all of them.

Source: SEC EDGAR 13F filings

AHR fails-to-deliver

SEC CNS data

On 14 Aug 2026, 2,249 shares of AHR failed to deliver (about $121K) — the latest of 3 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
14 Aug 2026 2,249 $121K 0.001%
13 Aug 2026 17,679 $930K 0.008%
12 Aug 2026 5 $263 <0.001%
05 Aug 2026 8,391 $457K 0.004%
04 Aug 2026 49 $3K <0.001%
29 Jul 2026 2,320 $134K 0.001%
24 Jul 2026 100 $6K <0.001%
23 Jul 2026 100 $6K <0.001%
22 Jul 2026 100 $6K <0.001%

Source: SEC fails-to-deliver (CNS) data